MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours
October 21, 2026 · 8:01 AM · AUSTIN, Texas
MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today published a white paper showing that its LensAI™ immunogenicity screening ran across an entire public antibody database of 890,634 sequences in 4 hours and 41 minutes on Amazon EC2 Hpc8a instances powered by 5th Gen AMD EPYC™ processors, delivering up to 43% lower cost per sequence than a comparable Intel configuration running identical code. “Every antibody drug carries a questio...
- PublishedOctober 21, 2026 · 8:01 AM
- LocationAUSTIN, Texas
- IndustryScience
- LanguageEN
Published by Business Wire. Read the original announcement for the full release.
Read the full announcement →